Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05212922
Title A Study to Evaluate YH001 in Combination With Toripalimab in Subjects With Advanced NSCLC and HCC (YH001)
Acronym YH001
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Eucure (Beijing) Biopharma Co., Ltd
Age Groups: adult | senior
Covered Countries AUT | AUS

Additional content available in CKB BOOST